The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Peptide-drug conjugates

Peptide-drug conjugates

Peptide-drug conjugates aim to transport inactive anti-tumor agent to malignant cells, which is then cleaved to an active cytotoxic drug. Such approach minimizes effect on healthy cells and leads to reduced adverse side effects. The peptide-drug conjugates consist of the tumor-homing peptide, the cytotoxic agent, and the biodegradable connecting linker.

|||